title: [Introduction].
authors: Catedrático de Oftalmología, Universidad de Sevilla, Sevilla, España Sociedad Española de Retina y Vítreo (SERV). Electronic address: apb@clinicapinero.com.
authors: A
authors: A
authors: Piñero
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D015337:Multicenter Studies as Topic; D000069579:Ranibizumab; D012164:Retinal Diseases / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab